Semi-Annual Balance Sheet

Carna Biosciences, Inc. - Filing #7718384

Concept As at
2018-09-30
As at
2017-12-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,144,152,000 JPY
1,856,218,000 JPY
Other
119,543,000 JPY
67,779,000 JPY
Current assets
1,523,199,000 JPY
2,134,250,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
14,923,000 JPY
20,381,000 JPY
Intangible assets
Intangible assets
239,000 JPY
405,000 JPY
Investments and other assets
Investments and other assets
90,846,000 JPY
35,349,000 JPY
Non-current assets
106,009,000 JPY
56,136,000 JPY
Assets
1,629,209,000 JPY
2,190,386,000 JPY
Liabilities
Current liabilities
Accounts payable - trade
3,422,000 JPY
3,026,000 JPY
Income taxes payable
10,274,000 JPY
19,259,000 JPY
Other
12,418,000 JPY
12,956,000 JPY
Current liabilities
408,129,000 JPY
341,966,000 JPY
Accounts payable - other
130,534,000 JPY
124,727,000 JPY
Non-current liabilities
Non-current liabilities
525,153,000 JPY
470,511,000 JPY
Bonds payable
116,000,000 JPY
144,000,000 JPY
Long-term borrowings
380,499,000 JPY
298,122,000 JPY
Asset retirement obligations
26,570,000 JPY
26,179,000 JPY
Other
2,083,000 JPY
2,209,000 JPY
Liabilities
933,282,000 JPY
812,477,000 JPY
Other liabilities
Other liabilities
Net assets
Share capital
3,297,318,000 JPY
3,226,487,000 JPY
Shareholders' equity
Capital surplus
Capital surplus
2,115,343,000 JPY
2,044,512,000 JPY
Retained earnings
Retained earnings
-4,729,836,000 JPY
-3,906,897,000 JPY
Treasury shares
-117,000 JPY
-99,000 JPY
Shareholders' equity
682,709,000 JPY
1,364,003,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-688,000 JPY
-55,000 JPY
Valuation and translation adjustments
-1,319,000 JPY
-1,186,000 JPY
Net assets
695,926,000 JPY
1,377,908,000 JPY
Share acquisition rights
14,537,000 JPY
15,092,000 JPY
Liabilities and net assets
1,629,209,000 JPY
2,190,386,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.